Cargando…
miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577794/ https://www.ncbi.nlm.nih.gov/pubmed/34726253 http://dx.doi.org/10.3892/ijo.2021.5280 |
| _version_ | 1784596134500499456 |
|---|---|
| author | Liu, Kai Liu, Songyang Zhang, Wei Ji, Bai Wang, Yingchao Liu, Yahui |
| author_facet | Liu, Kai Liu, Songyang Zhang, Wei Ji, Bai Wang, Yingchao Liu, Yahui |
| author_sort | Liu, Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8577794 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | D.A. Spandidos |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85777942021-11-10 miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma Liu, Kai Liu, Songyang Zhang, Wei Ji, Bai Wang, Yingchao Liu, Yahui Int J Oncol Retraction D.A. Spandidos 2021-11-01 /pmc/articles/PMC8577794/ /pubmed/34726253 http://dx.doi.org/10.3892/ijo.2021.5280 Text en Copyright: © Liu et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
| spellingShingle | Retraction Liu, Kai Liu, Songyang Zhang, Wei Ji, Bai Wang, Yingchao Liu, Yahui miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| title | miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| title_full | miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| title_fullStr | miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| title_full_unstemmed | miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| title_short | miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| title_sort | mir-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577794/ https://www.ncbi.nlm.nih.gov/pubmed/34726253 http://dx.doi.org/10.3892/ijo.2021.5280 |
| work_keys_str_mv | AT liukai mir222regulatessorafenibresistanceandenhancetumorigenicityinhepatocellularcarcinoma AT liusongyang mir222regulatessorafenibresistanceandenhancetumorigenicityinhepatocellularcarcinoma AT zhangwei mir222regulatessorafenibresistanceandenhancetumorigenicityinhepatocellularcarcinoma AT jibai mir222regulatessorafenibresistanceandenhancetumorigenicityinhepatocellularcarcinoma AT wangyingchao mir222regulatessorafenibresistanceandenhancetumorigenicityinhepatocellularcarcinoma AT liuyahui mir222regulatessorafenibresistanceandenhancetumorigenicityinhepatocellularcarcinoma |